CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | +100.0% | 599 | +103.1% | 0.00% | – |
| Q1 2022 | $2,000 | -80.0% | 295 | -79.9% | 0.00% | – |
| Q4 2021 | $10,000 | -9.1% | 1,465 | -30.8% | 0.00% | – |
| Q3 2021 | $11,000 | -15.4% | 2,116 | -5.1% | 0.00% | – |
| Q2 2021 | $13,000 | +30.0% | 2,229 | +5.3% | 0.00% | – |
| Q1 2021 | $10,000 | – | 2,116 | +1566.1% | 0.00% | – |
| Q4 2020 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |